Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery

NCT02006888 is registered in ClinicalTrials.gov with ICON Bioscience Inc as lead sponsor.

NCT NCT02006888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02006888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery
Lead sponsor
ICON Bioscience Inc
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
October 31, 2014
Enrollment
394 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataracts, inflammation